Key result
Medical therapy and invasive management of acute coronary syndrome improve outcomes in patients with cancer, emphasizing the need for appropriate patient selection and tailored therapy.
Why the study?
Improved cancer survival has made cardiovascular disease a major determinant of survivorship, prompting increased interest in managing cardiovascular disease during and after cancer treatment.
Tailored medical and invasive management of acute coronary syndrome improves outcomes in patients with cancer.
May inform ACS decisions in cancer patients; leaves open optimal selection pending prospective trials.
INTRODUCTION: Improvement in cancer survival has led to an increased focus on cardiovascular disease as the other major determinant of survivorship. As a result, there has been an increasing interest in managing cardiovascular disease during and post cancer treatment. AREAS COVERED: This article reviews the current literature on the pathogenesis, risk factors, presentation, treatment and clinical outcomes of acute coronary syndrome (ACS) in patients with cancer. EXPERT OPINION: There is growing evidence that both medical therapy and invasive management of ACS improve outcomes in patients with cancer. Appropriate patient selection, risk stratification and tailored therapy represents the cornerstone of management in these patients.
No takes yet. Share an insight, caveat, or question.
Shobayo et al. (2022) conducted a review in Acute coronary syndrome in patients with cancer. Medical therapy and invasive management was evaluated. Medical therapy and invasive management of acute coronary syndrome improve outcomes in patients with cancer, emphasizing the need for appropriate patient selection and tailored therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: